Blood Pressure Medications Recalled After Contamination With Potential Carcinogen

0
135

Drug manufacturers are recalling several medications containing the ingredient a contaminated version of valsartan, according to a press release from Health Canada on Tuesday.

The drugs being recalled are used to treat patients with high blood pressure to prevent heart attacks and stroke.

An impurity, N-nitrosodimethylamine, was found in the valsartan used in these medications, supplied by a Chinese company, Zhejiang Huahai Pharmaceuticals.

According to the United States Environmental Protection Agency, this substance is a potential carcinogen that could cause cancer and liver damage over the long-term.

Here’s a list of the affected medications, provided by Health Canada. For a complete list including drug identification and lot numbers, visit their website:

  • ACT-VALSARTAN 40MG FC TABLETS 100
  • ACT-VALSARTAN 80MG FC TABLETS 100
  • ACT-VALSARTAN 160MG FC TABLETS 100
  • SANDOZ VALSARTAN 40 MG
  • SANDOZ VALSARTAN 80 MG
  • SANDOZ VALSARTAN 160 MG
  • SANDOZ VALSARTAN 320 MG
  • SANIS VALSARTAN 40 MG
  • SANIS VALSARTAN 80 MG
  • SANIS VALSARTAN 160 MG
  • PRO DOC LIMITEE VALSARTAN 40 MG
  • PRO DOC LIMITEE VALSARTAN 80 MG
  • PRO DOC LIMITEE VALSARTAN 160 MG
  • PRO DOC LIMITEE VALSARTAN 320 MG
  • SIVEM PHARMACEUTICAL ULC VALSARTAN 40 MG
  • SIVEM PHARMACEUTICAL ULC VALSARTAN 80 MG
  • SIVEM PHARMACEUTICAL ULC VALSARTAN 160 MG
  • SIVEM PHARMACEUTICAL ULC VALSARTAN 320 MG
  • TEVA-VALSARTAN/HCTZ TABLETS PP 30s
  • TEVA-VALSARTAN/HCTZ TABLETS (Bulk)

LEAVE A REPLY

Please enter your comment!
Please enter your name here